Market ReportsOur market reports emphasize rapidly changing trends within the life science industry and emphasize profitable opportunities that companies in this sector can pursue. We use proprietary search technologies to estimate market size, market share, market growth, and market patterns (cyclicity within a calendar year). To supplement the “hard” data collected for each project, our market analysts add qualitative analysis to each report, providing a high-tech, high-touch result. Because we believe all customers should be repeat customers, all market reports are backed by a progressive 60-Day Money Back Guarantee. To serve of range of industry and government clients, reports can be purchased directly through this site, or alternatively, by fax, telephone, email or purchase order (P.O.). Click here for more information on purchasing.
Over the past year, the cord blood banking industry expanded through double digit growth, due to new entrants to the industry, as well as revenue growth at existing operations. Deeper analysis revealed that most cord blood banks fall into one of two “camps,” either experiencing flat-line growth (less than 3% per annum) or substantively building revenue (at a rate of 17% or more per annum). This finding begs the questions: What factors caused a substantial number of new cord blood banks to open up business in 2009? What will be the effect of these new entrants for existing competitors? What are the differences among the cord blood banks that are experiencing flat-line vs. substantive growth? In addition, this report includes survey results from 1,200 expectant parents. Statistical analysis of the results provide a roadmap for how cord blood banks can best communicate and market their services to potential clients.
Stem cells are primitive cells found in all multi-cellular organisms that are characterized by self-renewal and the capacity to differentiate into any mature cell type. Several broad categories of stem cells exist, including: embryonic stem cells (derived from blastocysts), fetal stem cells (obtained from aborted fetuses), adult stem cells (found in adult tissues), cord blood stem cells (isolated from umbilical tissue), cancer stem cells (which give rise to a clonal populations of cells that form tumors or disperse in the body), and animal stem cells (derived from non-human sources). This report characterizes the various stem cell types and analyzes opportunities across the market spectrum.
This report focuses on recent advances in MSC research applications, explores research priorities by market segment, highlights individual labs and end-users of MSC research products, explores the competitive environment for MSC research products, and provides 5-year growth and trend analysis. Additionally, this report provides guidance for companies that offer or wish to offer competitive stem cells products to this rapidly growing, well-funded research community.
Recently, neuronal stem cells (NSC) have become of profound interest to the research community due to their potential to be used in drug discovery and delivery applications, as well as for tools of neural toxicology assessment. NSC transplantation also represents a ground-breaking approach for treating a range of chronic neurological diseases and acute CNS injuries, including Parkinson's, Alzheimer's and spinal cord injury, among other conditions. This market report provides detailed analysis and growth projections for the NSC market environment, explores recent progress in NSC therapies, and presents opportunities for development of novel NSC research products, including cells, kits, assays, media and reagents.
Pharmacodynamic assays are assays that provide a method for quickly screening cell samples for a pharmacodynamic effect to a drug/test agent. Pharmacodynamic assay development has become an increasingly lucrative area of product development for research supply companies, as demand for the assays has risen following recent introduction of Phase 0 trials by the FDA. Phase 0 trials are known as human microdosing studies and are designed to speed up the development of promising drugs by establishing early on whether they interact with their expected targets. This market report characterizes the rapidly growing pharmacodynamic assays market, providing guidance for companies that wish to support development of pharmacodynamic assays.
Currently, a great deal of research being done on PARP, because its activity is linked to many diseases, including cancer, ischemia, diabetes, arthritis, inflammatory bowel disease, and septic shock. Of great therapeutical interest are PARP-1 inhibitors, as they exert a duel effect of inhibiting cell death and reducing inflammation. PARP inhibitors are effective as radiation-sensitizing agents and appear promising in the treatment of conditions involving oxidative stress. Quantification of PARP activity and identification of abnormal patterns of PARP degradation by proteases might also aid in diagnosis of conditions. Provision of PARP products to researchers worldwide represents a lucrative financial opportunity, which is explored in detail within this report.
Copyright © 2009 BioInformant Worldwide, L.L.C. All rights reserved. |
hESCs have been proposed for a range of applications, including toxicology testing, tissue engineering, and cellular therapies. Currently, the Wisconsin Alumni Research Foundation (WARF) holds a series of landmark patents that have made it the “gatekeeper” determining which research product companies have been allowed to create hESC products and what pharmaceutical companies have been able to develop hESC therapies. Since 1998, WARF has only entered into licensing agreements with 27 commercial partners. While Invitrogen, Becton Dickinson and Chemicon have disclosed licensing agreements with WARF, many research products companies have to explore less costly alternatives – such as circumventing claims, conducting research off-shore, using abnormal karyotypes, developing products for other species, or strategic collaborations. This report explores the complex IP landscape, as well as characterizes this rapidly growing market and the opportunities it presents.
| Home | Company |Resources |Products/Services |Contact Us |Sitemap |